The cell cycle regulator p27(kip1) contributes to growth and differentiation of osteoblasts

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3705-3711

  Drissi, Hicham ^a   Hushka, Dennet ^a   Aslam, Fauzia ^a   Nguyen, Que ^a   Buffone, Elizabeth ^a   Koff, Andrew ^b   Van Wijnen, André J ^a   Lian, Jane B ^a   Stein, Janet L ^a   Stein, Gary S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CALVARIA; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BONE NEOPLASMS; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL COUNT; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DNA; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOSARCOMA; RATS; SKULL; STROMAL CELLS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 17444430336     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell, 79: 573-582, 1994.
2. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
3. Planas-Silva, M. D., and Weinberg, R. A. The restriction point and control of cell proliferation. Curr. Opin. Cell Biol., 9: 768-772, 1997.
4. Murray, A. W. Creative blocks: cell-cycle checkpoints and feedback controls. Nature (Lond.), 359: 599-604, 1992.
5. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinder, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
6. Gu, Y., Turck, C. W., and Morgan, D. O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707-710, 1993.
7. 1 cyclin- dependent kinases. Cell, 75: 805-816, 1993.
8. Johnson, M., Dimitrov, D., Vojta, P. J., Barrett, J. C., Noda, A., Pereira-Smith, O. M., and Smith, J. R. Evidence for a p53-independent pathway for up-regulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog. 11: 59-64, 1994.
9. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
10. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., and Koff, A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
11. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
12. Lee, M. H., Reynisdottir, I., and Massague, J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9: 639-649, 1995.
13. Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., and Elledge, S. J. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9: 650-662, 1995.
14. Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., and Xiong, Y. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/ MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8: 2939-2952, 1994.
15. Chan, F. K., Zhang, J., Cheng, L., Shapiro, D. N., and Winoto, A. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Mol. Cell. Biol., 15: 2682-2688, 1995.
16. Hannon, G. J., and Beach, D. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
17. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
18. 1 arrest. Cell, 76: 1013-1023, 1994.
19. Agrawal, D., Dong, F., Wang, Y. Z., Kayda, D., and Pledger, W. J. Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells. Cell Growth Differ., 6: 1199-1205, 1995.
20. 1→S-phase progression. Curr. Opin. Cell Biol. 9: 773-781, 1997.
21. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
22. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., and Elledge, S. J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
23. Coats, S., Flanagan, W. M., Nourse, J., and Roberts, J. M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science (Washington DC), 272: 877-880, 1996.
24. Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., and Koff, A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell, 85: 721-732, 1996.
25. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., and Loh, D. Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85: 707-720, 1996.
26. Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L. H., Broudy, V., Perlmutter, R. M., Kaushansky, K., and Roberts, J. M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell, 85: 733-744, 1996.
27. Kip2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor β1. J. Biol. Chem., 274: 12197-12200, 1999.
28. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (Lond.), 387: 151-158, 1997.
29. Stein, G. S., Lian, J. B., Stein, J. S., van Wijnen, A. J., Frenkel, B., and Montecino, M. Mechanisms regulating osteoblast proliferation and differentiation. In: J. P. Bilezikian, L. G. Raisz, and G. A. Rodan (eds.), Principles of Bone Biology, pp. 69-86, San Diego: Academic Press, 1996.
30. Smith, E., Frenkel, B., Schlegel, R., Giordano, A., Lian, J. B., Stein, J. L., and Stein, G. S. Expression of cell cycle regulatory factors in differentiating osteoblasts: postproliferative up-regulation of cyclins B and E. Cancer Res., 55: 5019-5024, 1995.
31. Smith, E., Frenkel, B., MacLachlan, T. K., Giordano, A., Stein, J. L., Lian, J. B., and Stein, G. S. Post-proliferative cyclin E-associated kinase activity in differentiated osteoblasts: inhibition by proliferating osteoblasts and osteosarcoma cells. J. Cell. Biochem., 66: 141-152, 1997.
32. Owen, T. A., Aronow, M., Shalhoub, V., Barone, L. M., Wilming, L., Tassinari, M. S., Kennedy, M. B., Pockwinse, S., Lian, J. B., and Stein, G. S. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol., 143: 420-430, 1990.
33. Falla, N., van Vlasselaer, P., Bierkens, J., Borremans, B., Schoeters, G., and van Gorp, U. Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood, 82: 3580-3591, 1993.
34. Frenkel, B., Capparelli, C., van Auken, M., Bryan, J., Stein, J. L., Stein, G. S., and Lian, J. B. Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex. Endocrinology, 138: 2109-2116, 1997.
35. Majeska, R. J., Rodan, S. B., and Rodan, G. A. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology, 107: 1494-1503, 1980.
36. West, D. C., Sattar, A., and Kumar, S. A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells. Anal. Biochem., 147: 289-295, 1985.
37. Breen, E. C., Ignotz, R. A., McCabe, L., Stein, J. L., Stein, G. S., and Lian, J. B. TGF β alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J. Cell. Physiol., 160: 323-335, 1994.
38. Centrella, M., Horowitz, M. C., Wozney, J. M., and McCarthy, T. L. Transforming growth factor-β gene family members and bone. Endocrinol. Rev., 15: 27-39, 1994.
39. Harris, S. E., Bonewald, L. F., Harris, M. A., Sabatini, M., Dallas, S., Feng, J. Q., Ghosh-Choudhury, N., Wozney, J., and Mundy, G. R. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J. Bone Miner. Res., 9: 855-863, 1994.
40. Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L., Bast, R. C., Jr., Iglehart, J. D., and Marks, J. R. Transforming growth factor β 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ., 5: 1301-1307, 1994.
41. Lian, J. B., Staal, A., van Wijnen, A. J., Stein, J. L., and Stein, G. S. Biologic and molecular effects of vitamin D on bone. In: M. F. Holick (ed.), Vitamin D: Molecular Biology, Physiology, and Clinical Applications, pp. 175-193. Totowa, NJ: Humana Press, 1999.
42. Owen, T. A., Aronow, M. S., Barone, L. M., Bettencourt, B., Stein, G. S., and Lian, J. B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology, 128: 1496-1504, 1991.
43. Bortell, R., Owen, T. A., Shalhoub, V., Heinrichs, A., Aronow, M. A., Rochette-Egly, C., Lutz, Y., Stein, J. L., Lian, J. B., and Stein, G. S. Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein-DNA interactions at promoter regulatory elements. Proc. Natl. Acad. Sci. USA, 90: 2300-2304, 1993.
44. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β, Genes Dev., 9: 1831-1845, 1995.
45. Owen, M. Marrow stromal stem cells. J. Cell Sci., 10: 63-76, 1988.
46. Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., and Freedman, L. P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev., 10: 142-153, 1996.
47. Bellido, T., O'Brien, C. A., Roberson, P. K., and Manolagas, S. C. Transcriptional activation of the p21(WAF1, CIP1, SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem., 273: 21137-21144, 1998.
48. Lynch, M. P., Capparelli, C., Stein, J. L., Stein, G. S., and Lian, J. B. Apoptosis during bone-like tissue development in vitro. J. Cell. Biochem., 68: 31-49, 1998.
49. Globus, R. K., Doty, S. B., Lull, J. C., Holmuhamedov, E., Humphries, M. I., and Damsky, C. H. Fibronectin is a survival factor for differentiated osteoblasts. J. Cell Sci. 111: 1385-1393, 1998.
50. 1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
51. Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M. H., Massague, J., Crabtree, G. R., and Roberts, J. M. Interleukin-2-raediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
52. Onishi, T., and Hruska, K. Expression of p27Kip1 in osteoblast-like cells during differentiation with parathyroid hormone. Endocrinology, 138: 1995-2004, 1997.
53. Harvat, B. L., Wang, A., Seth, P., and Jetten, A. M. Up-regulation of p27Kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation. J. Cell Sci., 111: 1185-1196, 1998.
54. Tikoo, R., Casaccia-Bonnefil, P., Chao, M. V., and Koff, A. Changes in cyclin-dependent kinase 2 and p27kip1 accompany glial cell differentiation of central glia-4 cells. J. Biol. Chem., 272: 442-447, 1997.
55. Lynch, M. P., Stein, J. L., Stein, G. S., and Lian, J. B. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp. Cell Res. 216: 35-45, 1995.
56. KIP2 in the control of tissue growth and development. Genes Dev., 12: 3162-3167, 1998.
57. KIP2 control muscle differentiation at the myogenin step. Genes Dev., 13: 213-224, 1999.